Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Summit Therapeutics (SMMT)
NASDAQ:SMMT
Holding SMMT?
Track your performance easily
Summit Therapeutics (SMMT) Ownership Overview
80.14% Insiders
2.60% Mutual Funds
0.12% Other Institutional Investors
2.53% ETFs
14.61% Public Companies and Individual Investors
The ownership structure of Summit Therapeutics (SMMT) stock is a mix of institutional, retail, and individual investors. Approximately 5.25% of the company’s stock is owned by Institutional Investors, 80.14% is owned by Insiders, and 14.61% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Oct 03, 2024 | Maky Zanganeh Co Ceo,director | xxxxxxxxxxxxx | $498776 |
| Mar 27, 2024 | Maky Zanganeh Co Ceo,director | xxxxxxxxxxxxx | $411094 |
| Mar 27, 2024 | xxxxxxxxxxxxx | $375000 | |
| Dec 13, 2023 | Maky Zanganeh Co Ceo,director | xxxxxxxxxxxxx | $1204108 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Jun 30, 2024 | xxxxxxxxxxxxx | $152100 | |
| Jun 30, 2024 | xxxxxxxxxxxxx | $941818 | |
| Jun 30, 2024 | xxxxxxxxxxxxx | $181133331 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 551,695,096 | Insider | 74.81% | 12,010,402,240 | |
| 35,738,442 | Insider | 4.85% | 778,025,882 | |
| 23,222,222 | Institution | 3.15% | 505,547,773 | |
| 10,627,632 | Institution | 1.44% | 231,363,549 | |
| 7,752,569 | Institution | 1.05% | 168,773,427 | |
| 4,813,099 | Institution | 0.65% | 104,781,165 | |
| 4,784,429 | Institution | 0.65% | 104,157,019 | |
| 3,020,242 | Insider | 0.41% | 65,750,668 | |
| 1,664,374 | Institution | 0.23% | 36,233,422 | |
| 1,338,361 | Institution | 0.18% | 29,136,119 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 7,752,569 | Institution | 1.05% | 168,773,427 | |
| 4,784,429 | Institution | 0.65% | 104,157,019 | |
| 1,664,374 | Institution | 0.23% | 36,233,422 | |
| 992,476 | Institution | 0.13% | 21,606,203 | |
| 850,583 | Institution | 0.12% | 18,517,192 | |
| 750,000 | Institution | 0.10% | 16,327,500 | |
| 537,522 | Institution | 0.07% | 11,701,854 | |
| 525,834 | Institution | 0.07% | 11,447,406 | |
| 442,474 | Institution | 0.06% | 9,632,659 | |
| 272,395 | Institution | 0.04% | 5,930,039 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,427,980 | Institution | 0.46% | 75,072,762 | |
| 2,717,802 | Institution | 0.37% | 59,519,864 | |
| 2,399,427 | Institution | 0.33% | 52,235,526 | |
| 2,061,555 | Institution | 0.28% | 45,148,055 | |
| 1,842,797 | Institution | 0.25% | 40,357,254 | |
| 1,217,344 | Institution | 0.17% | 26,063,335 | |
| 744,383 | Institution | 0.10% | 16,205,218 | |
| 665,561 | Institution | 0.09% | 14,249,661 | |
| 605,183 | Institution | 0.08% | 13,174,834 | |
| 401,498 | Institution | 0.05% | 8,792,806 |
FAQ
Who Owns Summit Therapeutics (SMMT)?
According to the latest TipRanks data, approximately 0.12% of the company's stock is held by institutional investors, 80.14% is held by insiders, and 14.61% is held by retail investors.
What percentage of Summit Therapeutics (SMMT) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.12% of Summit Therapeutics (SMMT) stock is held by institutional investors.
What percentage of Summit Therapeutics (SMMT) stock is held by retail investors?
According to the latest TipRanks data, approximately 14.61% of Summit Therapeutics (SMMT) stock is held by retail investors.
Who owns the most shares of Summit Therapeutics (SMMT)?
Robert Duggan owns the most shares of Summit Therapeutics (SMMT).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.